<p><em>重新分类降低了研究的障碍，并消除了惩罚性的 280E 税负</em></p>
<p>, /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (&#34;Trulieve&#34;或&#34;公司&#34;), 是美国领先且表现优异的 cannabis 公司，赞扬特朗普政府采取的将大麻重新分类为《受控物质法》第三类的行动。</p>
<p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/1720011/Trulieve_LogoV1.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/1720011/Trulieve_LogoV1.jpg"/></p>
<p>&#34;特朗普总统的这一大胆且历史性的方向代表了长期以来的变革，是大麻改革的重要里程碑，&#34; Trulieve 首席执行官 Kim Rivers 表示。&#34;Trulieve 对政府采取的果断行动表示感谢，这一行动承认了大麻的医疗益处，支持持牌和受监管的运营商，并允许执法机构起诉不法行为者。我们致力于在整个过程中支持政府。&#34;</p>
<p>将大麻重新分类为第三类并不意味着大麻合法化，但这是实现切实可行的大麻改革的重要第一步。将大麻移至第三类为更深入的医疗大麻研究打开了大门，消除了《税法》第 280E 条款施加的惩罚性税负，并为执法机构保留了针对和惩罚非法运营商的灵活性。</p>
<p><strong>降低进行关键医疗大麻研究的障碍</strong> 将大麻重新分类为第三类承认了大麻的医疗益处，并降低了在美国进行医疗研究的限制。近年来，关于大麻特性和益处的前沿研究主要在其他国家进行，这些国家对研究的限制较少。随着这一变化，美国公司和大学可以在研究医疗应用以及适当剂量和形式方面领先，包括针对退伍军人和老年人的不同患者群体。</p>
<p><strong>消除对州合法大麻运营商施加的惩罚性 280E 税负</strong>《税法》第 280E 条款的实施是为了禁止销售第一类或第二类物质的毒贩对普通商业费用进行税收扣除。第 280E 条款的采用早于州合法大麻项目，因此并未明确区分外国贩毒集团等毒贩与受州监管机构严格监督的持牌运营商。根据定义，第 280E 条款不适用于第三类物质。消除 280E 税负有效支持提供经过测试、标记和年龄限制的大麻产品的州合法运营商。</p>
<p><strong>与更广泛的承诺一致，打击非法运营商和外国贩毒集团</strong> 重新分类大麻为大麻改革带来了常识，承认了大麻与海洛因和合成芬太尼等危险药物之间的区别。重新分类并不意味着大麻合法化。执法机构保留了积极打击非法运营商、保护我们的社区免受非法药物跨境流入的权力，并起诉向儿童销售大麻的不法行为者。</p>
<p><strong>关于 Trulieve</strong> Trulieve 是一家行业领先的垂直整合大麻公司和美国多州运营商，在亚利桑那州、佛罗里达州和宾夕法尼亚州拥有领先的市场地位。Trulieve 准备加速增长和扩展，通过其中心战略在新市场和现有市场中建立零售和分销规模。通过提供创新的高质量产品，Trulieve 在其品牌组合中提供最佳客户体验，并增加对大麻的获取，帮助患者和客户无障碍生活。Trulieve 在 CSE 上市，股票代码为 TRUL，并在 OTCQX 市场交易，股票代码为 TCNNF。有关更多信息，请访问 Trulieve.com。</p>
<p>Facebook: @Trulieve</p>
<p>Instagram: @Trulieve</p>
<p>X: @Trulieve</p>
<p><strong>投资者和媒体联系</strong> Christine Hersey，投资者关系副总裁</p>
<p>+1 (424) 202-0210</p>
<p>Christine.Hersey@Trulieve.com</p>
<p>来源 Trulieve Cannabis Corp.</p>

TCNNF

<p>Trulieve Cannabis Corp. 对特朗普政府决定将大麻重新分类为《受控物质法》下的第三类物质表示赞赏。此举减轻了研究障碍，消除了惩罚性的 280E 税负，并支持执法部门打击非法经营者。Trulieve 首席执行官 Kim Rivers 强调了这一变化对大麻改革的重要性以及大麻的医疗益处。重新分类允许进行更深入的医学研究，并支持合法州的大麻经营者</p>

<p><em>Reclassification Eases Barriers to Research and Removes Punitive 280E Tax Burden</em></p>
<div class="lb-trans"><p><em>重新分类降低了研究的障碍，并消除了惩罚性的 280E 税负</em></p>
</div><p>, /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (&#34;Trulieve&#34; or &#34;the Company&#34;), a leading and top-performing cannabis company in the U.S., applauds action taken by the Trump Administration to reclassify marijuana to Schedule III under the Controlled Substances Act.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (&#34;Trulieve&#34;或&#34;公司&#34;), 是美国领先且表现优异的 cannabis 公司，赞扬特朗普政府采取的将大麻重新分类为《受控物质法》第三类的行动。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/1720011/Trulieve_LogoV1.jpg" alt="" original-src="https://mma.prnewswire.com/media/1720011/Trulieve_LogoV1.jpg"/></p>
<p>&#34;This bold and historic direction from President Trump represents long overdue change and a major milestone in cannabis reform,&#34; said Trulieve Chief Executive Officer Kim Rivers. &#34;Trulieve is grateful for the decisive action taken by the Administration that acknowledges the medical benefits of cannabis, supports licensed and regulated operators, and allows law enforcement agencies to prosecute bad actors. We are committed to supporting the Administration throughout this process.&#34;</p>
<div class="lb-trans"><p>&#34;特朗普总统的这一大胆且历史性的方向代表了长期以来的变革，是大麻改革的重要里程碑，&#34; Trulieve 首席执行官 Kim Rivers 表示。&#34;Trulieve 对政府采取的果断行动表示感谢，这一行动承认了大麻的医疗益处，支持持牌和受监管的运营商，并允许执法机构起诉不法行为者。我们致力于在整个过程中支持政府。&#34;</p>
</div><p>Reclassification of marijuana to Schedule III does not legalize marijuana but it is an important first step in achieving practical common sense cannabis reform. Moving marijuana to Schedule III opens the door for more robust research of medical marijuana, removes the punitive tax burden imposed by Section 280E of the tax code, and retains flexibility for law enforcement to target and punish illicit operators.</p>
<div class="lb-trans"><p>将大麻重新分类为第三类并不意味着大麻合法化，但这是实现切实可行的大麻改革的重要第一步。将大麻移至第三类为更深入的医疗大麻研究打开了大门，消除了《税法》第 280E 条款施加的惩罚性税负，并为执法机构保留了针对和惩罚非法运营商的灵活性。</p>
</div><p><strong>Eases Barriers to Conducting Critical Medical Marijuana Research</strong> Reclassifying marijuana to Schedule III acknowledges the medical benefits of marijuana and eases restrictions on conducting medical research in the U.S. In recent years, cutting edge research on the properties and benefits of marijuana has primarily been conducted in other countries with fewer restrictions on research. With this change, American companies and universities can take the lead with research designed to delineate medical applications as well as appropriate dosages and form factors for various patient populations including veterans and seniors.</p>
<div class="lb-trans"><p><strong>降低进行关键医疗大麻研究的障碍</strong> 将大麻重新分类为第三类承认了大麻的医疗益处，并降低了在美国进行医疗研究的限制。近年来，关于大麻特性和益处的前沿研究主要在其他国家进行，这些国家对研究的限制较少。随着这一变化，美国公司和大学可以在研究医疗应用以及适当剂量和形式方面领先，包括针对退伍军人和老年人的不同患者群体。</p>
</div><p><strong>Removes Punitive 280E Tax Burden Imposed on State Legal Cannabis Operators</strong> Section 280E of the tax code was implemented to prohibit drug traffickers selling Schedule I or Schedule II substances from taking tax deductions for ordinary business expenses. The adoption of Section 280E preceded state legal marijuana programs and thus did not explicitly differentiate between drug traffickers such as foreign cartels and licensed operators subject to strict oversight by state regulators. By definition, Section 280E does not apply to Schedule III substances. Removing the 280E tax burden effectively supports state legal operators who provide patients and adults tested, labeled, and age-gated cannabis products.</p>
<div class="lb-trans"><p><strong>消除对州合法大麻运营商施加的惩罚性 280E 税负</strong>《税法》第 280E 条款的实施是为了禁止销售第一类或第二类物质的毒贩对普通商业费用进行税收扣除。第 280E 条款的采用早于州合法大麻项目，因此并未明确区分外国贩毒集团等毒贩与受州监管机构严格监督的持牌运营商。根据定义，第 280E 条款不适用于第三类物质。消除 280E 税负有效支持提供经过测试、标记和年龄限制的大麻产品的州合法运营商。</p>
</div><p><strong>Aligns With Broader Commitment to Stopping Illegal Operators and Foreign Cartels</strong> Rescheduling marijuana applies common sense to cannabis reform by recognizing the difference between marijuana and dangerous drugs such as heroin and synthetic fentanyl. Rescheduling does not legalize marijuana. Law enforcement agencies retain the authority to aggressively target illicit operators, protect our communities from illegal drugs crossing our borders, and prosecute bad actors selling marijuana to children.</p>
<div class="lb-trans"><p><strong>与更广泛的承诺一致，打击非法运营商和外国贩毒集团</strong> 重新分类大麻为大麻改革带来了常识，承认了大麻与海洛因和合成芬太尼等危险药物之间的区别。重新分类并不意味着大麻合法化。执法机构保留了积极打击非法运营商、保护我们的社区免受非法药物跨境流入的权力，并起诉向儿童销售大麻的不法行为者。</p>
</div><p><strong>About Trulieve</strong> Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S., with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.</p>
<div class="lb-trans"><p><strong>关于 Trulieve</strong> Trulieve 是一家行业领先的垂直整合大麻公司和美国多州运营商，在亚利桑那州、佛罗里达州和宾夕法尼亚州拥有领先的市场地位。Trulieve 准备加速增长和扩展，通过其中心战略在新市场和现有市场中建立零售和分销规模。通过提供创新的高质量产品，Trulieve 在其品牌组合中提供最佳客户体验，并增加对大麻的获取，帮助患者和客户无障碍生活。Trulieve 在 CSE 上市，股票代码为 TRUL，并在 OTCQX 市场交易，股票代码为 TCNNF。有关更多信息，请访问 Trulieve.com。</p>
</div><p>Facebook: @Trulieve</p>
<div class="lb-trans"><p>Facebook: @Trulieve</p>
</div><p>Instagram: @Trulieve</p>
<div class="lb-trans"><p>Instagram: @Trulieve</p>
</div><p>X: @Trulieve</p>
<div class="lb-trans"><p>X: @Trulieve</p>
</div><p><strong>Investor and Media Contact</strong> Christine Hersey, Vice President of Investor Relations</p>
<div class="lb-trans"><p><strong>投资者和媒体联系</strong> Christine Hersey，投资者关系副总裁</p>
</div><p>+1 (424) 202-0210</p>
<div class="lb-trans"><p>+1 (424) 202-0210</p>
</div><p>Christine.Hersey@Trulieve.com</p>
<div class="lb-trans"><p>Christine.Hersey@Trulieve.com</p>
</div><p>SOURCE Trulieve Cannabis Corp.</p>
<div class="lb-trans"><p>来源 Trulieve Cannabis Corp.</p>
</div>

Trulieve 赞扬特朗普政府将大麻重新分类为附表 III 的决定 | TCNNF 股票新闻